Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » FDA Grants Emergency Use Authorization for Coronavirus Assays From Hologic, LabCorp

FDA Grants Emergency Use Authorization for Coronavirus Assays From Hologic, LabCorp

Mar 16, 2020
|
staff reporter

NEW YORK – The US Food and Drug Administration on Monday granted Emergency Use Authorization for Hologic's Panther Fusion SARS-CoV-2 assay, the company announced after the close of the market.

The FDA also issued EUA to Laboratory Corporation of America's coronavirus assay, as the total number of emergency-use-authorized commercial assays for detecting SARS-CoV-2, which causes COVID-19, grew to four, in addition to EUA-designated tests from the US Centers for Disease Control and Prevention and the New York State Department of Health.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Analysis for the Long Term

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

Pricey, But Available

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Pilot Cancer Testing Program for Taiwan

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

PLOS Papers on TB Resistance, Squamous Cell Carcinoma Risk, MicroRNAs in SCC

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Issues EUA for Adaptive Biotechnologies COVID-19 T-Cell Response Test

  2. Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

  3. Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

  4. Luminex Obtains FDA Emergency Use Authorization for Expanded Respiratory Panel With SARS-CoV-2

  5. Qiagen MDx Sample Processing Platform Garners CE-IVD Mark

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.